Sorenson Genomics Laboratory Awarded Accreditation from College of American Pathologists

Sorenson Genomics Laboratory Awarded Accreditation from College of American Pathologists

<0> Sorenson Genomics Public RelationsJacob Moon, 801-461-9797Alex Koritz, 801-461-9795 </0>

Sorenson Genomics today announced that it has received accreditation from the College of American Pathologists (CAP) based on the results of a recent onsite inspection. CAP is the world's largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance.

Sorenson Genomics is the parent company of Identigene, the world’s largest provider of direct-access DNA testing services, and Sorenson Forensics, a leading provider of advanced forensic DNA testing for state crime laboratories and law enforcement agencies. The Sorenson Genomics laboratories specialize in molecular diagnostics, testing for sexually transmitted diseases, parentage testing, forensic DNA analysis and contract research.

The laboratory was advised of this national recognition and congratulated for the excellence of the service being provided. During the CAP accreditation process, inspectors examine the laboratory's records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, as well as the laboratory's equipment, facilities, safety program and record, in addition to the overall management of the laboratory. This stringent inspection program is designed to specifically ensure the highest standard of care for all laboratory patients.

“We are dedicated to adhering to the highest standards of testing in our laboratory, and this latest accreditation from CAP validates those efforts,” said Doug Fogg, chief operating officer of Sorenson Genomics. “In bringing together the most qualified people in an innovative environment that cultivates a culture of quality through operational efficiencies, we have built a world-class laboratory to help resolve challenging questions using molecular biology.”

Sorenson Genomics has validated a wide array of laboratory methodologies and maintains the industry’s highest degree of accreditation and standards. In addition to this new CAP accreditation, the laboratory holds accreditations from the AABB (formerly the American Association of Blood Banks) for parentage analysis, the Laboratory Accreditation Bureau (L-A-B) for general laboratory standards of ISO/IEC17025:2005, and the New York State Department of Health (NYSDOH). Sorenson Genomics laboratories also participate in regular proficiency testing to assess laboratory training and competency.

Sorenson Genomics’ Human Genomics DNA Testing Laboratory offers the capacity, instrumentation, expertise and accreditation requisite to producing revolutionary genetic testing solutions for clients around the world. Sorenson Genomics provides a wide spectrum of testing services including DNA extraction and purification, forensic DNA analysis, disaster victim identification, ancestral and population assessment, human genotyping and molecular diagnostics. Sorenson Genomics is a highly accredited Lean Six Sigma laboratory. Visit  for more information or engage with us on LinkedIn.

The CAP Laboratory Accreditation Program, begun in the early 1960s, is recognized by the federal government as being equal to or more stringent than the government's own inspection program. CAP, celebrating 50 years as the gold standard in laboratory accreditation, is a medical society that serves more than 17,000 physician members and global laboratory community. The College advocates accountable, high-quality, and cost-effective patient care. More information about the College can be found at .

Suggested Articles

German scientists are targeting a protein-cutting enzyme that many viruses, including the coronavirus COVID-19, need to replicate.

The 100 largest companies trading on the London Stock Exchange have boosted the percentage of women on their boards, but has life sciences kept pace?

In this week's EuroBiotech Report, Bicycle lands Genentech collaboration, GSK inks COVOD-19 adjuvant deal and Grifols buys antibiotic assets.